Please enable JavaScript.
Coggle requires JavaScript to display documents.
Introduction - Coggle Diagram
Introduction
Epidemiology
of HIV
https://example.com
transmission & risk factors
Prevalence and worldwide geographic distribution of HIV
Global HIV epidemic :
SubSaharan African HIV epidemic
HIV epidemic in Ethiopia
National HIV prevalence trends
womens HIV infection, treatment, adherance
History & classification of HIV
Pathogenisis
The Human Immunodeficiency Virus (HIV)
HIV infection and replication
Reservoirs of HIV infection
THE NATURAL COURSE OF HIV INFECTION
Acute phase
Asymptomatic phase
Symptomatic phase
HIV TREATMENT AND HIGHLY ACTIVE ANTIRETROVIRAL THERAPY
(HAART)
Historical perspective of HAART
HIV/AIDS, Highly Active Antiretroviral Therapy (HAART), and its
treatment benefits
Highly active antiretroviral drug classes
Eligibility criteria
Adherence to Highly Active Antiretroviral Therapy (HAART)
Benefits of adherence to Highly Active Antiretroviral Therapy
Consequences of non-adherence
Clinical implications to nonadherance
Public health consequences of nonadherance
HAART ADHERENCE PREPARATION BEFORE COMMENCING THE
TREATMENT
ADHERENCE ASSESSMENT DURING ANTIRETROVIRAL THERAPY
INTAKE
Level of adherence to HAART medication in developed countries
Level of adherence to HAART medication in sub-Saharan Africa
HAART Medication Adherence in Ethiopia
MEASUREMENT OF ADHERENCE
Self-report
Pharmacy/prescription refill records
Pill count
Electronic drug monitoring devices
Access to antiretroviral therapy
FACTORS THAT INFLUENCE ADHERENCE TO HAART
Patient-related factors
Socio-demographic and economic factors
Healthcare system-related factors
HAART medication-related factors
STRATEGIES RELATED TO HAART MEDICATION ADHERENCE
IMMUNE RESPONSES TO HIV INFECTION
LABORATORY DIAGNOSIS OF HIV INFECTION